Loss of a Conserved N-Linked Glycosylation Site in the Simian Immunodeficiency Virus Envelope Glycoprotein V2 Region Enhances Macrophage Tropism by Increasing CD4-Independent Cell-to-Cell Transmission-Reference-Cited by-同舟云学术

Loss of a Conserved N-Linked Glycosylation Site in the Simian Immunodeficiency Virus Envelope Glycoprotein V2 Region Enhances Macrophage Tropism by Increasing CD4-Independent Cell-to-Cell Transmission

Published:2014-02-19 Issue:9 Volume:88 Page:5014-5028
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:Journal of Virology

Author:

Yen P.-J.,Herschhorn A.,Haim H.,Salas I.,Gu C.,Sodroski J.,Gabuzda D.

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Reference101 articles.

1. The plasma membrane as a combat zone in the HIV battlefield;Doms;Genes Dev.,2000

2. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens;Wyatt;Science,1998

3. Determinants within gp120 and gp41 contribute to CD4 independence of SIV Envs;Puffer;Virology,2004

4. A conserved determinant in the V1 loop of HIV-1 modulates the V3 loop to prime low CD4 use and macrophage infection;Musich;J. Virol.,2011

5. The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia;Dunfee;Proc. Natl. Acad. Sci. U. S. A.,2006

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. mRNA-based HIV-1 vaccines;Clinical Microbiology Reviews;2024-09-12

2. Alternative substitutions of N332 in HIV-1 _AD8 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycan;mBio;2024-04-10

3. HIResist: a database of HIV-1 resistance to broadly neutralizing antibodies;Bioinformatics;2024-02-29

4. Ultrasensitive quantification of HIV-1 cell-to-cell transmission in primary human CD4 ⁺ T cells measures viral sensitivity to broadly neutralizing antibodies;mBio;2024-01-16

5. Enhancing anti-viral neutralization response to immunization with HIV-1 envelope glycoprotein immunogens;npj Vaccines;2023-11-24